水野 桂

The Clock and the Scalpel: Does delayed Robot-assisted radical prostatectomy affect pathological progression and upgrading in prostate cancer? 

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 51(10) 110357-110357 2025年10月  

Development of a novel risk model to predict CRPC progression following IMRT: Implications for tailoring treatment intensity. 

BJUI compass 6(9) e70074 2025年9月  

Intraindividual epigenetic heterogeneity underlying phenotypic subtypes of advanced prostate cancer. 

Nature communications 16(1) 5543-5543 2025年7月1日  

Two-Stage Tumor Resection for Locally Advanced Renal Cell Carcinoma With Level IV Tumor Thrombus and Pulmonary Embolism: A Case Report. 

IJU case reports 8(4) 382-385 2025年7月  

Clinical Outcomes of Metastasis-directed Therapy for Oligo-metastatic Prostate Cancer Diagnosed Using PSMA-PET/CT or Whole-body MRI. 

Anticancer research 45(6) 2515-2525 2025年6月  

Highly hypofractionated biaxially rotational dynamic radiation therapy (BROAD-RT) for high-risk prostate cancer. 

Cancer science 116(4) 1004-1011 2025年4月  

Case Report: Genomic insights into prostate adenocarcinoma transdifferentiation to carcinosarcoma due to lineage plasticity. 

Frontiers in oncology 15 1576048-1576048 2025年  

Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes. 

Nature communications 15(1) 6779-6779 2024年8月8日  

Notch signaling suppresses neuroendocrine differentiation and alters the immune microenvironment in advanced prostate cancer. 

The Journal of clinical investigation 134(17) 2024年7月18日  

Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation. 

Cancer discovery 14(3) 424-445 2024年3月1日  

Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trial. 

Journal of the National Cancer Institute 116(1) 115-126 2024年1月10日  

TREX1 inactivation unleashes cancer cell STING-interferon signaling and promotes anti-tumor immunity. 

Cancer discovery 2024年1月10日  

Newly developed preclinical models reveal broad-spectrum CDK inhibitors as potent drugs for CRPC exhibiting primary resistance to enzalutamide. 

Cancer science 115(1) 283-297 2024年1月  

Targeting DNA methylation and B7-H3 in RB1-deficient and neuroendocrine prostate cancer. 

Science translational medicine 15(722) eadf6732 2023年11月15日  

Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer. 

Nature cancer 4(5) 699-715 2023年5月  

Up-regulation of secretory leukocyte protease inhibitor in human samples might have a potential role of predicting prostate cancer recurrence and progression after surgery and hormonal therapy. 

Cancer medicine 12(3) 3328-3342 2023年2月